Skip to content
★ Sign in to follow
BF

Bent Frandsen

ExpreS2ion Biotech Holding AB (EXPRS2)
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
31
Company
1
▲ Purchases (5 ops.)
€29k
▼ Sales (10 ops.)
€37k

Latest filing published 30 Apr 2026 for ExpreS2ion Biotech Holding AB (EXPRS2), €54.

Filing timeline

BuySale
Bent Frandsen

Insider track record

Disclosed buys
5
Disclosed sells
10
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-37.0%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bent Frandsen: trading record in brief

Bent Frandsen appears in our data through filings on ExpreS2ion Biotech Holding AB (EXPRS2) shares, published by Finansinspektionen. Over a trading history stretching from 25 February 2021 to 20 April 2026, the count stands at 31 filings.

The open-market side counts 5 purchases for €29k alongside 10 sales for €37k. The net balance comes to €7,412 on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at no purchases and 4 sales.

A typical purchase (the median) is worth €4,116.

Most recently, on 30 April 2026, the filings show an open-market sale worth €54 in ExpreS2ion Biotech Holding AB (EXPRS2). The clock since the last published purchase (17 November 2024) now reads 720 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Bent Frandsen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total

25 of 29 declarations